Nektar Therapeutics (NKTR) Social Stream



Nektar Therapeutics (NKTR): $3.23

-0.01 (-0.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NKTR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 381

in industry

NEKTAR THERAPEUTICS (NKTR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NKTR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-28 8 $29 $18 $21.444 $3.28 553.78%
2022-03-01 8 $29 $17 $20.666 $3.28 530.06%
2022-03-02 9 $29 $17 $20.777 $3.28 533.45%
2022-03-09 9 $29 $12 $19.888 $3.28 506.34%
2022-03-15 10 $29 $5 $12.555 $3.28 282.77%
2022-04-18 10 $29 $4.7 $12.077 $3.28 268.2%
2022-04-25 10 $29 $4.7 $11.966 $3.28 264.82%
2022-05-06 10 $20 $4.7 $9.837 $3.28 199.91%
2022-05-17 10 $20 $4.6 $9.7 $3.28 195.73%
2022-05-31 10 $20 $4 $8.7 $3.28 165.24%
2022-06-08 9 $20 $4 $6.943 $3.28 111.68%
2022-08-08 9 $6 $4 $4.766 $3.28 45.3%
2022-09-17 8 $6 $4 $4.783 $3.28 45.82%
2022-11-07 9 $6 $4 $4.783 $3.28 45.82%

The Trend in the Analyst Price Target


Over the past 35 weeks, NKTR's average price target has gone down $15.11.

NKTR reports an average of 87.13% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-25 8 29 18.0 21.444 10.90 96.73%
2022-03-02 9 29 12.0 19.888 10.75 85%
2022-03-15 10 29 5.0 12.555 4.48 180.25%
2022-05-17 10 20 4.6 9.700 3.94 146.19%
2022-09-17 8 6 4.0 4.783 3.47 37.84%

NKTR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3.33 0 0 7 1 1 9

The Trend in the Broker Recommendations


NKTR's average broker recommendation rating worsened by 1.08 over the prior 14 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NKTR as an investment opportunity.

  • In the context of all US stocks, NEKTAR THERAPEUTICS's average analyst price target is higher than 219.48% of them.
  • NEKTAR THERAPEUTICS's variance in analysts' estimates is lower than -1303.72% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, NEKTAR THERAPEUTICS's upside potential (average analyst target price relative to current price) is higher than 1505.1% of them.
  • NKTR has a higher number of analysts covering the stock than 1265.86% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, BHC, VRTX, and IONS are the three stocks most similar to NEKTAR THERAPEUTICS regarding the price target and analyst recommendation information presented here.

What is the outlook for NKTR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7254 seconds.